{
  "ticker": "BOT",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02966165",
  "id": "02966165",
  "pages": 3,
  "price_sensitive": false,
  "date": "20250704",
  "time": "1333",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250704/pdf/06lgwml6hd7mnm.pdf",
  "summary": "- **Webinar Announcement**: Botanix Pharmaceuticals to host a webinar on 8 July 2025 (9:30am AEST) to provide an update on Sofdra\u2122's initial demand and performance.  \n- **Key Product**: Sofdra\u2122 is the first FDA-approved treatment for primary axillary hyperhidrosis.  \n\n*No material trading or capital markets information identified.*",
  "usage": {
    "prompt_tokens": 1598,
    "completion_tokens": 80,
    "total_tokens": 1678,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-04T03:59:59.011862"
}